Improving the Efficacy of Adoptive T Cell Therapy by Leveraging the Polyclonality of TIL
Time: 4:15 pm
day: Day One
Details:
• Efficacy of polyclonal TIL: current data in solid tumors
• What’s next: genetically modified TIL
• Ensuring success and access to TIL therapy
